179 related articles for article (PubMed ID: 25862893)
1. Histopathologic features predictive of aggressiveness of post-transplant cutaneous squamous-cell carcinomas.
Kanitakis J; Karayannopoulou G; Roux A; Euvrard S
Anticancer Res; 2015 Apr; 35(4):2305-8. PubMed ID: 25862893
[TBL] [Abstract][Full Text] [Related]
2. Tumour Budding Correlates with Aggressiveness of Cutaneous Squamous-cell Carcinoma.
Karayannopoulou G; Euvrard S; Kanitakis J
Anticancer Res; 2016 Sep; 36(9):4781-5. PubMed ID: 27630328
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma of the scalp in organ transplant recipients: exploring mechanisms for recurrence and treatment guidelines.
Neubauer KE; Goldstein GD; Plumb SJ
Dermatol Surg; 2010 Feb; 36(2):185-93. PubMed ID: 20039923
[TBL] [Abstract][Full Text] [Related]
6. High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population.
Pandeya N; Isbel N; Campbell S; Chambers DC; Hopkins P; Soyer HP; Jiyad Z; Plasmeijer EI; Whiteman DC; Olsen CM; Green AC
JAMA Dermatol; 2023 Aug; 159(8):854-858. PubMed ID: 37314794
[TBL] [Abstract][Full Text] [Related]
7. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients.
Lott DG; Manz R; Koch C; Lorenz RR
Transplantation; 2010 Sep; 90(6):683-7. PubMed ID: 20808266
[TBL] [Abstract][Full Text] [Related]
8. Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.
Lanz J; Bouwes Bavinck JN; Westhuis M; Quint KD; Harwood CA; Nasir S; Van-de-Velde V; Proby CM; Ferrándiz C; Genders RE; Del Marmol V; Forchetti G; Hafner J; Vital DG; Hofbauer GFL
JAMA Dermatol; 2019 Jan; 155(1):66-71. PubMed ID: 30516812
[TBL] [Abstract][Full Text] [Related]
9. Basosquamous cell carcinoma in organ transplant patients: a clinicopathologic study.
Mougel F; Kanitakis J; Faure M; Euvrard S
J Am Acad Dermatol; 2012 May; 66(5):e151-7. PubMed ID: 21696852
[TBL] [Abstract][Full Text] [Related]
10. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with large cutaneous squamous cell carcinomas.
Renzi C; Mastroeni S; Passarelli F; Mannooranparampil TJ; Caggiati A; Potenza C; Pasquini P
J Am Acad Dermatol; 2010 Sep; 63(3):404-11. PubMed ID: 20598396
[TBL] [Abstract][Full Text] [Related]
12. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.
Carucci JA; Martinez JC; Zeitouni NC; Christenson L; Coldiron B; Zweibel S; Otley CC
Dermatol Surg; 2004 Apr; 30(4 Pt 2):651-5. PubMed ID: 15061850
[TBL] [Abstract][Full Text] [Related]
13. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
[TBL] [Abstract][Full Text] [Related]
14. Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients.
Krynitz B; Lundh Rozell B; Lindelöf B
Acta Derm Venereol; 2010 Jul; 90(4):379-85. PubMed ID: 20574603
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
[TBL] [Abstract][Full Text] [Related]
16. Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas.
Rival-Tringali AL; Euvrard S; Decullier E; Claudy A; Faure M; Kanitakis J
Anticancer Res; 2009 Jun; 29(6):1927-32. PubMed ID: 19528449
[TBL] [Abstract][Full Text] [Related]
17. Clear-cell differentiation and lymphatic invasion, but not the revised TNM classification, predict lymph node metastases in pT1 penile cancer: a clinicopathologic study of 76 patients from a low incidence area.
Mannweiler S; Sygulla S; Tsybrovskyy O; Razmara Y; Pummer K; Regauer S
Urol Oncol; 2013 Oct; 31(7):1378-85. PubMed ID: 22421354
[TBL] [Abstract][Full Text] [Related]
18. Aggressive squamous cell carcinomas in organ transplant recipients.
Euvrard S; Kanitakis J; Pouteil-Noble C; Disant F; Dureau G; Finaz de Villaine J; Claudy A; Thivolet J
Transplant Proc; 1995 Apr; 27(2):1767-8. PubMed ID: 7725494
[No Abstract] [Full Text] [Related]
19. Metastasis Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Immunocompetent Patients.
Genders RE; Osinga JAJ; Tromp EE; O'Rourke P; Bouwes Bavinck JN; Plasmeijer EI
Acta Derm Venereol; 2018 Jun; 98(6):551-555. PubMed ID: 29405246
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
